ImmunityBio, Inc. IBRX Debt-to-equity
Discontinued — last reported Q3 '20
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from ImmunityBio, Inc.’s reported figures.
Based on the most recent quarter.
The official record: ImmunityBio, Inc.’s 10-Q, filed November 12, 2021, on SEC EDGAR. View the filing →
Questions, answered.
- What does debt-to-equity mean?
- How much debt the company carries for every dollar of shareholder equity.
- How do you interpret debt-to-equity?
- Lower is generally safer, but moderate leverage can boost returns. Read in the context of cash-flow stability — a utility tolerates more debt than a cyclical. Negative equity makes the ratio meaningless and it is suppressed there.
- How does debt-to-equity compare across companies?
- Comparable within an industry; capital structures differ sharply across sectors. Not meaningful for banks.